Full Paper
The residue was purified by chromatography on silica gel (hex-
anes/ethyl acetate) to afford the desired (10-hydroxyphenanthren-
9-yl)(phenyl)methanone 3a–s.
(10-Hydroxyphenanthren-9-yl)(phenyl)methanone (3a): 1H NMR
(500 MHz, CDCl3): d=12.75 (s, 1H), 8.60 (dd, J=11.2, 4.3 Hz, 2H),
8.53 (d, J=8.2 Hz, 1H), 7.86–7.76 (m, 1H), 7.69 (dd, J=11.6, 4.5 Hz,
1H), 7.66–7.61 (m, 2H), 7.56–7.51 (m, 1H), 7.42–7.33 (m, 4H),
7.18 ppm (qd, J=7.0, 3.5 Hz, 1H); 13C NMR (126 MHz, CDCl3): d=
200.19, 160.64, 140.34, 133.99, 132.41, 130.59, 130.25, 129.42,
128.45, 127.65, 127.08, 126.13, 125.89, 125.21, 125.05, 124.40,
122.83, 122.59, 110.97 ppm; IR (neat): n˜ =1617, 1447, 1305, 1010,
753, 722 cmÀ1; HRMS: m/z calcd for C21H15O2+: 299.1067 [M+H+];
found: 299.1069.
General procedure B: Gold-catalyzed oxidation/cyclopropanation
of ynone 5 to 6a-benzoyl-1-phenyl-1a, 6a-dihydrocyclopropa[a]in-
den-6(1H)-one (6). To a 3 dram vial containing 3 mL of PhF were
added sequentially the ynone 5 (0.15 mmol), 8-methylqunoline N-
oxide N-oxide 2a (29 mg, 0.225 mmol, 1.2 equiv), and Mor-DalPho-
sAuNTf2 (6.9 mg, 0.003 mmol). The resulting mixture was stirred at
258C and the progress of the reaction was monitored by TLC.
Upon completion, the reaction mixture was concentrated under
vacuum. The residue was purified by chromatography on silica gel
(hexanes/ethyl acetate) to afford the desired 6a-benzoyl-1-phenyl-
1a, 6a-dihydrocyclopropa[a]inden-6(1H)-one (6).
Figure 4. Salicyl ketone analogue 3c reduces the proliferation of cancer
cells. The IC50 values represent the concentration resulting in 50% inhibition
of cell proliferation. Cells were grown and treated with 3c at 0–2 mm, PC-3
cells for 48 h, and SKOV-3 cells for 72 h. All data (mean ÆSD) are the aver-
age of three determinations.
indicated IC50 values of 0.81Æ0.05 and 0.87Æ0.15 mm, respec-
tively, demonstrating that the salicyl ketone analogues exhibit
good anticancer activity (Figure 4).
6a-Benzoyl-1-phenyl-1a,6a-dihydrocyclopropa[a]inden-6(1H)-one
(6): 1H NMR (500 MHz, CDCl3): d=7.92–7.86 (m, 2H), 7.75 (d, J=
7.6 Hz, 1H), 7.61–7.55 (m, 2H), 7.49–7.44 (m, 1H), 7.41–7.33 (m,
3H), 7.17–7.09 (m, 5H), 4.13 (d, J=4.3 Hz, 1H), 3.24 ppm (d, J=
4.4 Hz, 1H); 13C NMR (126 MHz, CDCl3): d=195.36, 191.42, 151.67,
136.72, 134.43, 134.08, 133.98, 133.37, 130.25, 128.36, 127.94,
127.81, 127.71, 127.36, 125.62, 125.01, 57.17, 53.83, 30.73 ppm. IR
(neat): n˜ =1711, 1658, 1347, 1009, 752, 684 cmÀ1; HRMS: m/z calcd
for C23H17O2+: 325.1223 [M+H+]; found: 325.1225.
Conclusion
We have described an efficient strategy to construct salicyl ke-
tones through gold-catalyzed oxidation/CÀH functionalization
of ynones. A variety of functionalized salicyl ketones are readily
accessed by utilizing this non-diazo approach, thus providing
a viable alternative route to synthetically useful salicyl ketones.
The anticancer activity of salicyl ketone analogue 3c against
the PC-3 and prostate cancer cell line and SKOV-3 human ovar-
ian carcinoma cell line was also investigated and showed good
biological activity.
Acknowledgements
We are grateful for the financial support from National Natural
Science Foundation of China (NSF-21502150) and Youth Train-
ing Programme and Northwest A&F University (Z111021404).
Experimental Section
General experimental details: Column chromatography was car-
ried out on silica gel. Unless noted, H NMR spectra were recorded
1
Keywords: antitumor agents · carbenes · CÀH activation ·
gold · oxidation
at 500 MHz in CDCl3 and 13C NMR spectra were recorded at
125 MHz in CDCl3 with trimethylsilane (TMS) as internal standard.
IR spectra were recorded with a FTIR spectrometer, and only the
major peaks are reported (in cmÀ1). Melting points were deter-
mined with a microscopic apparatus and are uncorrected. All new
compounds were further characterized by elemental analysis or
[1] a) J. W. Lampe, C. K. Biggers, J. M. Defauw, R. J. Foglesong, St. E. Hall,
J. M. Heerding, S. P. Hollinshead, H. Hu, P. F. Hughes, G. E. Jagdmann, Jr.,
M. G. Johnson, Y.-S. Lai, C. T. Lowden, M. P. Lynch, J. S. Mendoza, M. M.
Murphy, J. W. Wilson, L. M. Ballas, K. Carter, J. W. Darges, J. E. Davis, F. R.
vastava, H. O. Saxena, K. Shanker, J. K. Kumar, S. Luqman, M. M. Gupta,
4608; c) G. R. Reddy, C.-C. Kuo, U.-K. Tan, M. S. Coumar, C.-Y. Chang, Y.-K.
Chiang, M.-J. Lai, J.-Y. Yeh, S.-Y. Wu, J.-Y. Chang, J.-P. Liou, H.-P. Hsieh, J.
[3] For a monograph, see: M. P. Doyle, M. A. McKervey, T. Ye, Modern Cata-
lytic Methods for Organic Synthesis with Diazo Compounds: From Cyclo-
propanes to Ylides, Wiley, Hoboken, 1998.
1
high-resolution mass spectrometry (HRMS); copies of their H and
13C NMR spectra are provided in the Supporting Information. De-
tailed data of 3k and X-ray crystallographic studies of 3k are also
provided. Commercially available reagents and solvents were used
without further purification. THF was distilled immediately prior to
use.
General procedure A: Gold-catalyzed oxidation/CÀH functionaliza-
tion of ynones to functionalized polycyclic salicyl ketones 3. To
a 3 dram vial containing 3 mL of PhF were added sequentially
ynone 1a–s (0.15 mmol), 8-methylqunoline N-oxide 2a (29 mg,
0.225 mmol, 1.2 equiv), and Ph3PAuNTf2 (5.5 mg, 0.003 mmol). The
resulting mixture was stirred at 258C or the indicated temperature,
and the progress of the reaction was monitored by TLC. Upon
completion, the reaction mixture was concentrated under vacuum.
[4] For examples of gold carbenes generated from a-diazo carbonyl com-
pounds, see: a) M. R. Fructos, T. R. Belderrain, P. de Fremont, N. M. Scott,
Fructos, M. Mar Dꢁaz-Requejo, P. J. Pꢂrez, P. Pꢂrez-Galꢃn, N. Delpont,
&
&
Chem. Eur. J. 2016, 22, 1 – 6
4
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!